Basic information Safety Supplier Related

DOTA-NOC, DOTA-[Nal3]-octreotide

Basic information Safety Supplier Related

DOTA-NOC, DOTA-[Nal3]-octreotide Basic information

Product Name:
DOTA-NOC, DOTA-[Nal3]-octreotide
Synonyms:
  • DOTA-NOC
  • DOTA-NOC acetate
  • L-Cysteinamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)-L-alanyl-Dtryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic(2)-disulfide
  • DOTA-NOC619300-53-7
  • DOTA-NOC, DOTA-[Nal3]-octreotide
  • L-Cysteinamide, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)-L-alanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2-7)-disulfide
  • DOTA-[Nal3]-octreotide
  • 2-[[10-(4-aminobutyl)-7-(1-hydroxyethyl)-13-(1~{H}-indol-3-ylmethyl)-16-(naphthalen-1-ylmethyl)-6,9,12,15,18-pentaoxo-19-[[3-phenyl-2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propanoyl]amino]-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]amino]-3-hydroxybutanoic acid
CAS:
619300-53-7
MF:
C69H92N14O18S2
MW:
1469.68178
Mol File:
619300-53-7.mol
More
Less

DOTA-NOC, DOTA-[Nal3]-octreotide Chemical Properties

solubility 
PBS (pH 7.2): Sparingly soluble: 1-10 mg/ml
Sequence
DOTA-{d-Phe}-Cys-{Nal}-{d-Trp}-Lys-Thr-Cys-Thr-ol (Disulfide bridge: Cys2-Cys7)
InChIKey
VMOLIPGHXGTESU-UHFFFAOYSA-N
CAS DataBase Reference
619300-53-7
More
Less

DOTA-NOC, DOTA-[Nal3]-octreotide Usage And Synthesis

Chemical Properties

Colourless to off-white lyophilised solid

Uses

DOTA-NOC (DOTA-Nal3-octreotide) is a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5. DOTA-NOC can be used for labeling with various radiometals, and development of radiopeptide imaging[1]. DOTA-NOC can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs).

IC 50

RDC Peptide

References

[1] Wild D, et al. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals. Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1338-47. DOI:10.1007/s00259-003-1255-5
[2] JOHAN HYGUM DAM. Preparation and Evaluation of [18F]AlF-NOTA-NOC for PET Imaging of Neuroendocrine Tumors: Comparison to [68Ga]Ga-DOTA/NOTA-NOC.[J]. Molecules, 2022. DOI: 10.3390/molecules27206818

DOTA-NOC, DOTA-[Nal3]-octreotideSupplier

Hangzhou Baige Pharmaceutical Technology Co. , Ltd. Gold
Tel
0571-85350119 15888826472
Email
15888826472@163.com
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Email
info@chemlin.com.cn
Creative Peptides
Tel
Email
info@creative-peptides.com
Shanghai Chaolan Chemical Technology Center
Tel
021-QQ:65489617 15618227136
Email
Sales@ATKchemical.com
Hangzhou Peptidego Biotech Co.,Ltd.
Tel
0571-87213919
Email
Eric@peptidego.com
More
Less

DOTA-NOC, DOTA-[Nal3]-octreotide(619300-53-7)Related Product Information